BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 17037026)

  • 1. [Carcinogenic mechanisms and anticarcinogenesis].
    Kavetskiĭ RE
    Vopr Onkol; 2005; 51(6):632-5. PubMed ID: 17037026
    [No Abstract]   [Full Text] [Related]  

  • 2. [The modifications of mutagenesis and anticarcinogenesis].
    Khudoleĭ VV
    Vestn Ross Akad Med Nauk; 1993; (1):34-41. PubMed ID: 7682121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The 4th International Conference on Mechanisms of Antimutagenesis and Anticarcinogenesis: a summary.
    Liviero L; von Borstel RC
    Mutat Res; 1996 Feb; 350(1):287-93. PubMed ID: 8657193
    [No Abstract]   [Full Text] [Related]  

  • 4. Mechanistic approaches to chemoprevention of mutation and cancer.
    Ferguson LR; Bronzetti G; De Flora S
    Mutat Res; 2005 Dec; 591(1-2):3-7. PubMed ID: 16095634
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antimutagenesis and anticancer effects.
    Bronzetti G; Della Croce C; Aretini P; Fiorio R
    J Environ Pathol Toxicol Oncol; 1996; 15(2-4):59-64. PubMed ID: 9216786
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Janus carcinogens and mutagens.
    von Borstel RC; Higgins JA
    Mutat Res; 1998 Jun; 402(1-2):321-9. PubMed ID: 9675327
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antimutagenesis/anticarcinogenesis 2001: screening, methods and biomarkers.
    Lohman PH; Gentile JM; Gentile G; Ferguson LR
    Mutat Res; 2001 Sep; 496(1-2):1-4. PubMed ID: 11551474
    [No Abstract]   [Full Text] [Related]  

  • 8. Direct interception of mutagens and carcinogens by biomolecules.
    Hartman PE; Hartman Z
    Basic Life Sci; 1993; 61():351-66. PubMed ID: 8304946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective role of glutathione, thiols, and analogues in mutagenesis and carcinogenesis.
    Jernström B; Morgenstern R; Moldéus P
    Basic Life Sci; 1993; 61():137-47. PubMed ID: 8304926
    [No Abstract]   [Full Text] [Related]  

  • 10. A brief history of the use of laboratory animals for the prediction of carcinogenic risk for man with a note on needs for the future.
    Roe FJ
    Exp Toxicol Pathol; 1998 Sep; 50(4-6):271-6. PubMed ID: 9783998
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Antimutagens and anticarcinogenic agents, identification and mechanisms of action of food xenobiotics].
    el Hamss R; Idaomar M
    Therapie; 2002; 57(6):512-7. PubMed ID: 12666257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New approaches to antimutagenesis.
    Heddle JA; Moody J; Thompson LU; Torous DK; Trentin G
    J Environ Pathol Toxicol Oncol; 1999; 18(2):95-101. PubMed ID: 15281220
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carcinogenicity of food mutagens.
    Sugimura T; Nagao M; Wakabayashi K
    Environ Health Perspect; 1996 May; 104 Suppl 3(Suppl 3):429-33. PubMed ID: 8781358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of natural biopolymers in genotoxicity of mutagens/carcinogens elimination.
    Miadoková E; Svidová S; Vlcková V; Dúhová V; Prazmáriová E; Tothová K; Nad'ová S; Kogan G; Rauko P
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2005 Dec; 149(2):493-6. PubMed ID: 16601818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Third International Conference on Mechanisms of Antimutagenesis and Anticarcinogenesis.
    De Flora S; Bronzetti G; Weisburger JH
    Cancer Epidemiol Biomarkers Prev; 1991; 1(1):95-9. PubMed ID: 1688263
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Tularemia live vaccine as a modifier of tumorigenesis and carcinogenesis].
    Nersesian AK; Galstian AM; Adamian RT
    Vopr Onkol; 2004; 50(1):28-35. PubMed ID: 15088516
    [No Abstract]   [Full Text] [Related]  

  • 17. Carcinogenic potency and interspecies extrapolation.
    Krewski D; Goddard MJ; Withey JR
    Prog Clin Biol Res; 1990; 340D():323-34. PubMed ID: 2196582
    [No Abstract]   [Full Text] [Related]  

  • 18. Multiple steps in carcinogenesis, multiple carcinogenic factors, and multiple primary tumors: can we develop an appropriate response for cancer prevention?
    Nagao M; Sugimura T
    Drug Metab Rev; 1998 May; 30(2):405-19. PubMed ID: 9606610
    [No Abstract]   [Full Text] [Related]  

  • 19. Mechanisms of antimutagenesis and anticarcinogenesis: role in primary prevention.
    De Flora S; Izzotti A; Bennicelli C
    Basic Life Sci; 1993; 61():1-16. PubMed ID: 8304921
    [No Abstract]   [Full Text] [Related]  

  • 20. Porphyrins as potential inhibitors against exposure to carcinogens and mutagens.
    Hayatsu H; Negishi T; Arimoto S; Hayatsu T
    Mutat Res; 1993 Nov; 290(1):79-85. PubMed ID: 7694102
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.